The United States allegedly can produce 100 million doses of bird flu “vaccines” within months, should the ruling class declare it another plandemic. The U.S. government has two candidate vaccine viruses for H5N1 bird flu that could be used to make vaccines.

Even though it hasn’t mutated to readily infect and spread amongst humans, the government somehow knows which mutations it will take and has those vaccines already prepared and can produce more at will. This is starting to feel like another mass vaccination agenda could begin anytime.

According to a report by Healthline, studies suggest vaccines based on these would offer good protection against the bird flu virus circulating among cattle in the U.S. The ruling class isn’t concerned about making all of these “vaccines.” Its concern is that they won’t be able to convince people to take them.

“These [candidate vaccine viruses] are like seed stock that are kept in reserve in case there is an outbreak of that particular strain,” said David Diemert, MD, a professor of medicine in the School of Medicine and Health Sciences at George Washington University, and director of the GW Vaccine Research Unit.

But it probably won’t matter if that particulate strain is the one infecting humans or not. And it’s going to likely mutate even more making it less effective. So what’s the point in creating all these shots unless they have a vaccine agenda?

If bird flu started easily spreading to people, “[the candidate vaccine virus] can be sent to manufacturers to make millions of doses of vaccine,” Diemert said, “using the existing hen egg technology that we normally use for the regular seasonal vaccine.”

Bird Flu “Vaccines” Are “Authorized” & “Warehoused” As CDC Demands Human Surveillance

Long before there was even a potential for bird flu to infect and spread among humans, the rulers were warehousing “vaccines.” Is this just one more instance of a coincidence? Preparedness? Or something else, like another plandemic getting ready to unfold?

Read the full article here

Share.

Comments are closed.